AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
39 hedge funds and large institutions have $16.7M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
39
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$4.32M | |
| 2 | +$3.43M | |
| 3 | +$374K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$221K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$126K |
Top Sellers
| 1 | -$572K | |
| 2 | -$187K | |
| 3 | -$91K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$54K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$31.9K |